SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-026023
Filing Date
2022-09-16
Accepted
2022-09-16 09:00:33
Documents
13
Period of Report
2022-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34538
2 ex10-1.htm EX-10.1 33364
  Complete submission text file 0001493152-22-026023.txt   242118

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ther-20220729.xsd EX-101.SCH 3230
4 XBRL LABEL FILE ther-20220729_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ther-20220729_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3280
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
THERALINK TECHNOLOGIES, INC. (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-52218 | Film No.: 221247044
SIC: 2834 Pharmaceutical Preparations